Prognostic significance of troponin T in acute myocardial infarction

Sunil Prasobh Prabhakaran, Abhilash Kannan


Background: Cardiac markers traditionally have been used only to establish the diagnosis in patients with acute coronary syndromes. In those with suspected acute STEMI, markers have been deemed to have little value, although smaller studies have suggested that troponin T may be valuable for risk stratification. Study aim was to study the prognostic significance of admission Troponin T in acute STEMI and also the relation between Troponin positivity and ST segment resolution after thrombolysis and also relationship with ejection fraction by echocardiogram.

Methods: This was a descriptive study conducted in 50 patients admitted with acute STEMI within eight hours in the department of medicine in a tertiary care centre in South Kerala. A blood sample was sent for assessing troponin T. All Patients underwent thorough clinical examination and investigations including echocardiogram was done and were managed with thrombolysis. They were closely followed up for in hospital and 30 days mortality and complications. ST segment resolution after thrombolysis with streptokinase was also assessed.

Results: In present study 48% of the patients were troponin T positive. Total six patients died of which all were Troponin T positive. There was a significant increase in the complications in troponin T positive group (46% vs 16%). 44% of the patients had an anterior wall myocardial infarction of which 46% had complications. ST segment resolution after thrombolysis was below 30% in 66.7% of the troponin T positive patients. Ejection fraction was below 50% in 80% of troponin T positive patients.

Conclusions: There was a statistically significant correlation between admission troponin T levels and in hospital complications and also mortality rates at 30 days. Troponin T positivity at admission was significantly associated with lower rates of reperfusion after thrombolysis with streptokinase and also lower rate of ejection fraction on echocardiogram. Troponin T positive anterior wall myocardial infarction was associated with more complications than non-anterior wall myocardial infarction.


Ejection fraction, STEMI, Streptokinase, Troponin T, Thrombolysis

Full Text:



Yusuf S, Pearson M, Sterry H, Parish S, Ramsdale D, Rossi P, et al. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. Eur Heart J. 1984;5:640-6.

GISSI Investigators. Italian group for streptokinase study in myocardial infarction (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.

Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902-12.

Collinson PO, Stubbs P. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:1760-1.

Burlina A, Zaninotto M, Secchiero S, Rubin D, Accorsi F. Troponin T as a marker of ischemic myocardial injury. Clin Biochem. 1994;27:113-21.

Wu A, Valdes R, Apple F, Gornet T, Ingersoll-Stroubus I, Mayfield-Stokes S, et al. Cardiac troponin T immunoassay for diagnosis of acute myocardial infarction and detection of minor myocardial injury. Clin Chem. 1994;40:900-7.

Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW. Cardiac troponin T levels for risk stratification in acute myocardial ischemia: GUSTOII an Investigators. N Engll J Med. 1996;335:1333-41.

Ohman EM, Armstrong PW, White HD, Granger CB, Wilcox RG, Weaver WD. Risk stratification with a point-of-care cardiac troponin T test in an acute myocardial infarction: the GUSTO-III Investigators. Am J Cardiol. 1999;84:1281-6.

Stubbs P. Collinson P. Moseley D, Greenwood T, Noble M. Risk stratification with appoint-of-care cardiac troponin T concentrations in myocardial infarction. Circulation. 1996;94:1291-7.

Giannitsis E, Muller-Bardorff M, Lehrke S, Wiegand U, Tolg R, Weidtmann B, et al. Admission troponin T level predicts clinical outcomes, TIMI flow, andmyocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation. 2001;104:630-5.

Matetzky S, Sharir T, Domingo M, Noc M, Chyu KY, Kaul S, et al. Elevated troponin T level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation. 2000;102:1611-6.

Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, et al. Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST elevation myocardial infarction. Crit Care Med. 2002;30(10):2229-35.

Reddy KS, Shah P, Shrivastava U, Prabhakaran D, Joshi M, Puri SK, et al. Coronary heart disease risk factors in an industrial population of North India. Can J Cardiol. 1997;13(l B):3.

Yadav NA, Raghu K, Patnaik AN, Krishna LSR, Gouthami V. Emerging risk factors in acute myocardial infarction: a tertiary care centre study. Indian Heart J. 2003;55:(5):19.

Kazmi KA, Iqbal MP, Rahbar A, Mehboobali N. Admission troponin T is a prognostic marker and its relationship to streptokinase treatment in patients with acute myocardial infarction. Trop Doct . 2003;33(1):18-22.

Rao AC, Collinson PO, Rose AJ, John C, Canepa-Anson R, Joseph SP. Prospective evaluation of role of routine cardiac troponin T measurement to identify left ventricular ejection fraction less than 40% after first myocardial infarction. Heart. 2003;89:559-60.